Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell MobilizationBone MarrowBone Marrow TransplantationLeukapheresisBone Marrow CellsGranulocyte Colony-Stimulating FactorHematopoietic Stem CellsStem CellsTransplantation, HomologousBlood Component RemovalAntigens, CD34Transplantation ConditioningHematologic NeoplasmsGraft vs Host DiseaseMelphalanCyclophosphamideCombined Modality TherapyBone and BonesGraft SurvivalMultiple MyelomaStem Cell TransplantationBlood CellsBusulfanAntineoplastic Combined Chemotherapy ProtocolsBone Marrow DiseasesBlood Cell CountHematopoiesisCord Blood Stem Cell TransplantationTreatment OutcomeBone Marrow PurgingLymphoma, Non-HodgkinTissue DonorsEtoposideAntineoplastic Agents, AlkylatingMyeloablative AgonistsTransplantation ChimeraThiotepaRecurrenceWhole-Body IrradiationRemission InductionHistocompatibilityLeukemiaColony-Forming Units AssayFlow CytometryCell DifferentiationPlatelet CountCell SeparationHistocompatibility TestingIfosfamideBlood DonorsAnemia, AplasticTime FactorsEmbryonic Stem CellsImmunophenotypingCytarabineCells, CulturedDisease-Free SurvivalLeukocytes, MononuclearLeukocyte CountInfectionAdult Stem CellsRecombinant ProteinsTransplantation, IsogeneicLeukemia, Myeloid, AcuteBone RemodelingVidarabinePOEMS SyndromeVincristineRetrospective StudiesSalvage TherapyImmunomagnetic SeparationImmunosuppressive AgentsBone Marrow ExaminationSurvival RateHodgkin DiseaseStem Cell FactorAntigens, CDLymphomaT-LymphocytesSurvival AnalysisBone Marrow NeoplasmsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNeoplasmsCarmustineMyelodysplastic SyndromesGranulocytesHematologic DiseasesLymphocyte DepletionProchlorperazinePlatelet TransfusionPluripotent Stem CellsGranulocyte-Macrophage Colony-Stimulating FactorLeukocyte TransfusionAmyloidosisStem Cell NicheDoxorubicinCell Count